Levemir Novo Nordisk Inc. - Treatment for Diabetes Mellitus (Type 1 and Type 2)
Levemir is a novel, long- acting form of insulin that provides up to a 24-hour duration of action for the treatment of diabetes mellitus (type 1 and type 2).Posted: June 2005
Related articles
- FDA Approves Levemir for Expanded Use in Children Two to Five Years of Age with Type 1 Diabetes - May 22, 2012
- FDA Approves Levemir Pregnancy Category Change for Women with Diabetes - April 2, 2012
Levemir (insulin detemir ) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
